These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 12128286)

  • 21. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovary syndrome: a new direction in treatment.
    Kidson W
    Med J Aust; 1998 Nov; 169(10):537-40. PubMed ID: 9861912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
    Moran L; Norman RJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):719-36. PubMed ID: 15380143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome.
    Pirotta S; Joham A; Grieger JA; Tay CT; Bahri-Khomami M; Lujan M; Lim SS; Moran LJ
    Semin Reprod Med; 2020 Nov; 38(6):342-351. PubMed ID: 33873233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovary syndrome and weight management.
    Moran LJ; Lombard CB; Lim S; Noakes M; Teede HJ
    Womens Health (Lond); 2010 Mar; 6(2):271-83. PubMed ID: 20187731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing polycystic ovary syndrome in primary care.
    Lua ACY; How CH; King TFJ
    Singapore Med J; 2018 Nov; 59(11):567-571. PubMed ID: 30498839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why does Polycystic Ovary Syndrome (PCOS) Need Long-term Management?
    Ruan X; Li M; Mueck AO
    Curr Pharm Des; 2018; 24(39):4685-4692. PubMed ID: 30706800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome. Long term sequelae and management.
    Legro RS
    Minerva Ginecol; 2002 Apr; 54(2):97-114. PubMed ID: 12032449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G; Davidson CR; Billings DL
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study.
    Lim S; Smith CA; Costello MF; MacMillan F; Moran L; Ee C
    BMC Endocr Disord; 2019 Oct; 19(1):106. PubMed ID: 31647000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of lifestyle changes in the treatment of polycystic ovary syndrome.
    Smyka M; Grzechocinska B; Wielgos M
    Neuro Endocrinol Lett; 2018 Feb; 38(8):521-527. PubMed ID: 29504728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.